Bard 1 Ovarian-assay development completed, 22 peptide RUO kits delivered. So, it is de-risked as it is capable of being used on Luminex instrumentation(using procarta plex technology) and optimisation is progressing. Extended agreement with Thermo Fisher and expect Luminex to be there soon for the commercial development.
Bard 1 Breast Cancer is inextricably linked with Bard 1 Ovarian-same autoantibody test.
Bard 1 Lung is well progressed for coming assay development on Luminex platform.
- Forums
- ASX - By Stock
- Thoughts on BD1?
Bard 1 Ovarian-assay development completed, 22 peptide RUO kits...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
59.0¢ |
Change
-0.010(1.67%) |
Mkt cap ! $65.06M |
Open | High | Low | Value | Volume |
59.5¢ | 59.5¢ | 58.0¢ | $4.527K | 7.767K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 38600 | 57.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.0¢ | 198 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 38600 | 0.575 |
1 | 14513 | 0.570 |
2 | 21481 | 0.565 |
3 | 28887 | 0.560 |
5 | 8900 | 0.555 |
Price($) | Vol. | No. |
---|---|---|
0.590 | 198 | 1 |
0.595 | 21999 | 3 |
0.610 | 12000 | 2 |
0.620 | 17907 | 3 |
0.625 | 1584 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |